Selected announcements from Gelonghui (Hong Kong stocks) | WUXI BIO (02269.HK) intends to sell assets related to the Irish vaccine facility for 0.5 billion US dollars.

【Today's Focus】WUXI BIO (02269.HK) plans to sell assets related to the Ireland vaccine facility for 0.5 billion USD. WUXI BIO (02269.HK) announced that on January 6, 2025, the company and WUXI HAI DE Ireland (the seller, a wholly-owned subsidiary of the company) entered into an agreement with MSD International (the buyer), according to which, subject to the terms and conditions of the agreement, the seller has conditionally agreed to sell and the buyer has conditionally agreed to purchase assets related to the Ireland vaccine facility, with a total consideration of approximately 500 million USD. The Ireland vaccine facility produces commercial products for the buyer.

Gelonghui FinanceJan 6 09:57 ET

Prosus Well-Placed for Sustained Growth -- Market Talk

WSJJan 6 06:41 ET

On January 6, TENCENT (00700.HK) spent 0.701 billion Hong Kong dollars to repurchase 1.71 million shares.

On January 6, Gelonghui丨TENCENT (00700.HK) announced that on January 6, 2025, it spent 0.701 billion Hong Kong dollars to repurchase 1.71 million shares, with a repurchase price per share ranging from 407.4 to 415 Hong Kong dollars.

Gelonghui FinanceJan 6 04:13 ET

Express News | Tencent Bought Back 1.7 Mln Shares for HK$701 Mln on Jan 6- HKEX Filing

ReutersJan 6 04:12 ET

Citi reaffirms TENCENT (00700) "Buy" rating with a Target Price of 573 Hong Kong dollars.

Citigroup has listed Tencent as a preferred stock and a core Hold Position.

Zhitong FinanceJan 6 03:24 ET

Tencent's Share Capital Falls to 9.2 Billion Shares

MT NewswiresJan 6 03:10 ET